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Spontaneous coronary artery dissection (SCAD) 
has been recognized as a relatively uncom-
mon disease for several years. The condition, 
although described, was poorly characterized 
in the era before intravascular imaging. As 
a result, women with SCAD were often misdi-
agnosed with an atheromatous acute coronary 
syndrome (ACS), MINOCA, or takotsubo car-
diomyopathy. Increasing numbers of recent 
studies, including large registries, confirm that 
it should no longer be called a “rare” disease. 
These studies provided new information about 
the incidence, pathophysiological concepts, 
methods of diagnosis, and the treatment of this 
condition [1–9].
This paper aims to increase the awareness 
of SCAD among clinicians who take care of 
patients with acute coronary syndromes in 
the emergency room, through the catheteri-
zation laboratory, cardiology wards, to general 
practitioners. We present the recommenda-
tions regarding the identification of SCAD on 
angiography, the indications for the use of 
intravascular imaging, the methods of acute 
treatment, and long-term post-SCAD manage-
ment. As prospective randomized trials are not 
available, these recommendations are based 
on retrospective analyses of series of patients 
or reflect experts’ consensus. 
WHAT IS SCAD?
Spontaneous coronary artery dissection is 
a non-atherosclerotic, non-traumatic, and 
non-iatrogenic disease of the coronary ar-
tery wall. It is a cause of the ACS and sudden 
cardiac death, especially among young and 
middle-aged women [1, 5, 6, 8]. Pathophysio-
logically, two potential mechanisms for SCAD 
have been proposed. First, the “inside-out” 
mechanism, where an intimal tear allows blood 
from the vessel lumen to enter the artery wall 
leading to dissection and false lumen for-
mation. Second, the “outside-in” mechanism 
assumes that the primary event is bleeding 
from microvessels (vasa vasorum) traversing 
the arterial wall. With both mechanisms, the 
intramural hematoma causes compression 
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of the true lumen resulting in compromised blood flow 
(Figure 1). Recent intracoronary imaging studies have 
shown that in a large proportion of SCAD cases, an intimal 
tear is not present or is preceded by intramural hematoma 
development, supporting the “outside-in” hypothesis as the 
predominant mechanism for SCAD [10–13].
INCIDENCE, PRECIPITATING RISK 
FACTORS, COMORBIDITIES, AND CLINICAL 
PRESENTATION
The true prevalence of SCAD remains unknown as this 
is still an underdiagnosed disease. In recently published 
studies, SCAD accounted for 0.3%–1.2% of all ACS cases 
[3, 14–16] (Table 1). 
This condition affects predominantly young and mid-
dle-aged women (more than 70% of cases reported in sev-
eral studies) [5]. The reported prevalence of SCAD in women 
below 50 years of age presenting with ACS ranges from 
6.6 to 35% [14, 16, 17–22]. No ethnic variations have been 
reported. The frequency of conventional risk factors for 
ischemic heart disease has often been considered minimal. 
Still, observational studies show these are certainly not neg-
ligible — hypertension was diagnosed in 18%–57% cases, 
hyperlipidemia in 10%–52%, and smoking in 11%–57% [5, 
8]. Indeed, in a recent analysis of more than 30 000 patients 
presenting with ACS, SCAD patients (n = 375) were more 
often hypertensive than non-SCAD ACS patients [3]. This 
critical finding may potentially change the paradigm that 
SCAD afflicts predominantly healthy women.
The cause of SCAD remains unknown. The predominance 
in young and middle-aged women, together with the asso-
ciation with pregnancy (predominantly the 3rd trimester) and 
Figure 1. Pathophysiology of spontaneous coronary dissection (Images used courtesy of BeatSCAD, www.beatscad.org.uk)
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Motreff (2017) 36/3224 1.1 15.3 100 52.7/47.3 18.2 27.3 10.9
Meng (2017) 21/60b — 35.0 100b 57.1/42.9 4.8 33.3 NR
Abreu (2018) 27/5002 0.5 NR 81.4 37.0/55.5 3.7 55.6 44.4
Clare (2019) 208/26598 0.78 NR 88.9 19.7/85.5 10.8 30.8 27.9
Inohara (2020) 322/68909 0.5 6.6 100a NR NR 58.7 40.1
de Roeck (2020) 27/102b — 26.5 100b 51.9/40.7 7.4 7.4 11.1
Krittawong (2020) 375/30427 1.2 NR 64.3 NR NR 54.7 NR
aOnly women included; bOnly women up to 50 years of age included.
Abbreviations: ACS, acute coronary syndrome; NR, not reported; NSTEMI, non-ST segment elevation myocardial infarction; STEMI, ST segment elevation myocardial infarction
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the postpartum period, suggests a potential pathophysio-
logical role of female sex hormones. However, the evidence 
of how this impacts mechanistically is still lacking [23]. Also, 
the following diseases or conditions were reported in case 
reposts or small case series, however, the potential causal 
relationship remains unproven: depression, hypothyroid, 
celiac disease, cryoglobulinemia, multiparity [5]. 
Spontaneous coronary artery dissection may have 
a genetic background in some cases (see Genetics section).
Among SCAD-related precipitating factors, extreme 
physical or emotional stress was most commonly iden-
tified [24–26]. Other potential factors, like Valsalva-type 
activities (sexual activity, weightlifting), use of recreational 
drugs (cocaine, amphetamine), high-doses of steroids, or 
caffeinated energy drinks binge, have been described in 
single-case reports [25, 27–33]. The majority of patients 
with SCAD present with typical symptoms of ACS [1, 5, 6, 
8]. However, in some cases, the pain may be atypical (back 
pain, pleuritic, positional, or burning), or dyspnea may be 
present. If it occurs in a young, healthy woman, the symp-
toms may be falsely interpreted as non-cardiac, leading 
to a delayed or even missed diagnosis of ACS. Thus, SCAD 
should always be considered in the differential diagnosis 
of ACS presentations in this low-risk population.
In approximately 8% of patients, SCAD-ACS can also 
present with cardiac arrest, ventricular arrhythmia, or 
cardiogenic shock [1, 34, 35]. Reported ECG findings at 
presentation vary in terms of different proportions of ST- 
-elevation myocardial infarction (STEMI)/non-STEMI 
(NSTEMI), but mainly favoring NSTEMI [8, 19, 21, 36]. In the 
largest cohort of a Canadian registry, including 750 pa-
tients, the proportion of NSTEMI/STEMI ACS subjects was 
70% versus 30%, respectively [1]. 
DIAGNOSIS OF SCAD
Invasive coronary angiography
Invasive coronary angiography constitutes the primary 
modality for the diagnosis of SCAD [4, 5]. Coronary an-
giography should be performed with particular caution 
and using coaxial catheter alignment as an increased risk 
of catheter-induced iatrogenic dissections is observed in 
these patients [37, 38]. A Canadian study reported a 10-fold 
higher risk of iatrogenic dissection during angiography in 
SCAD patients as compared to non-SCAD angiography 
(2% vs 0.2%) [37].
The European Society of Cardiology (ESC) Position Pa-
per differentiates four major angiographic types of SCAD, 
with type 2 further stratified into 2a and 2b subtypes [5].
Type 1 is characterized by a double linear lumen with 
angiographic radiolucent ‘flap’ and contrast staining, re-
sulting from a connection between true and false lumen 
(Figure 2A). While this is considered a pathognomonic 
SCAD presentation, it accounts only for one-third of SCAD 
patients [4, 26]. 
The remaining types have no double-lumen appear-
ance and sometimes may be missed or misdiagnosed by 
an unaware or inexperienced operator. 
Type 2 is visible as diffuse and predominantly smooth 
stenosis, typically located in the middle or distal segments 




Jacek Kądziela et al., The diagnosis and management of spontaneous coronary artery dissection
w w w . j o u r n a l s . v i a m e d i c a . p l / k a r d i o l o g i a _ p o l s k a
of the artery. The narrowing is usually long with smooth 
borders (usually longer than 20 mm) as a result of lumen 
compression by intramural hematoma with no communica-
tion between the false and true lumen and no penetration 
of contrast in the false lumen. It is the most frequently 
observed pattern reported in 55%–78% of all spontaneous 
dissections [1, 4, 8, 13]. Type 2 is subdivided into Type 2a, 
in which the narrowing reconstitutes downstream into the 
normal vessel, and Type 2b, in which the stenosis extends to 
the most distal segment (Figure 2B and 2C). In most clinical 
scenarios, Type 2 SCAD can be recognized based on coro-
nary angiography alone. However, in some cases, the final 
diagnosis may require additional intracoronary imaging 
to distinguish with certainty from atherosclerotic lesions.
Type 3 mimics focal atherosclerotic lesion and can be 
conclusively differentiated only with intracoronary imaging 
(Figure 2D). The stenosis is usually shorter, being caused 
by focal, non-propagated mural hematoma. It has been 
reported in approx. 10% of patients [1, 8]. 
Type 4 is defined as a total occlusion, usually in a dis-
tal segment of the artery (Figure 2E). It can often only 
be recognized as SCAD when the flow is restored, either 
through coronary intervention or following vessel healing 
(at angiographic follow-up) and after exclusion of coronary 
embolism. This type is an addition to the original Yip-Saw 
angiographic classification of SCAD, in which only three 
types were distinguished [38]. 
The coronary distribution of SCAD has been widely 
investigated: the left anterior descending artery and its 
territory are the most commonly affected (in approximately 
half of the cases), the left main is less frequently involved 
(up to 4% of cases) [21, 36, 39, 40]. The middle and distal 
segments of coronary arteries are predominantly affected 
(more than 90%); in less than 10%, the dissection is present 
in proximal parts of the major coronary artery or the left 
main [26, 29, 30]. Other angiographic features reported 
in SCAD patients included increased coronary tortuosity, 
reduced incidence or absence of atherosclerosis, coronary 
fibromuscular dysplasia, association of sites of dissection 
with myocardial bridging [5].
Multivessel SCAD is defined as simultaneous dissec-
tions occurring in more than one artery, without continuity, 
and is thus distinct from continuous dissection extending 
into the side branch. Multivessel SCAD occurs in 5%–23% 
of cases with no established risk factors [11, 36, 39, 40]. 
Intravascular imaging
Given that angiographic diagnosis is possible in most cas-
es, intracoronary imaging is best reserved for ambiguous 
lesions [6, 37, 41]. This refers particularly to patients with 
deceptive Type 3 SCAD, which mirrors atherosclerotic 
disease, and selected patients with 2 type dissection. It 
might also facilitate percutaneous coronary interventions 
(PCI) optimization and confirmation of appropriate stent 
expansion and apposition [4, 5]. 
Intravascular ultrasound (IVUS) allows for differentiation 
between atherosclerotic plaque and SCAD as it can depict 
the true and false lumen and the extent of intramural 
hematoma. Superior penetration ensuring complete vis-
ualization of the entire vessel wall without pressurized 
contrast injection are perceived as the main advantages 
of IVUS, compared with optical coherence tomography 
(OCT) [37, 42]. However, poor spatial resolution frequently 
limits the quality of imaging leaving significant diagnos-
tic uncertainty and higher-resolution imaging is a better 
option if available.
With its superb spatial resolution (10–20 um), OCT en-
ables detailed visualization of the intima-media complex, 
false lumen, presence of the thrombus, and fenestrations 
or connections between the true and false lumen. The 
benefits of OCT have to be weighed against the poten-
tial risk of further dissection propagation related to the 
high-pressure contrast injection required for good quality 
image acquisition (Figure 3). Thus, the modality should be 
limited to ambiguous lesions and to cases where imaging 
is required for clinical reasons (i.e., PCI optimization) Nev-
ertheless, recent evidence suggests that OCT interrogation 
can be safely performed in SCAD patients [10, 12, 16, 42, 43].
Computed tomography coronary angiography 
(CCTA)
Computed tomography is a widely used tool for coronary 
assessment in low- and intermediate-risk patients present-
ing with chest pain using the triple “rule-out” protocol. 
However, in many cases, SCAD may be missed or unde-
tectable on CCTA because of its lower spatial resolution 
(particularly in distal segments) [44–46]. Thus, a negative 
CCTA result cannot exclude a diagnosis of SCAD in some 
patients. In the case of biomarker confirmed myocardial 
necrosis in young or middle-aged women presenting with 
ACS, coronary angiography should be always considered 
despite a negative CCTA result. 
ACUTE MANAGEMENT OF SCAD
These recommendations on SCAD management are based 
solely on widely accepted consensus and observational 
data as there are currently no randomized trials comparing 
revascularization and conservative strategy [4–6]. 
A conservative approach to revascularization is recom-
mended in most patients, considering that observational 
studies showed spontaneous healing of the vessel wall in 
most patients and a high complication rate in the subgroup 
treated with PCI [21, 37, 47–49]. In a recent angiographic 
follow-up study, restoration of vascular architecture was 
observed in 86.3% of patients. This ratio increased to 95.0% 
when repeated coronary angiography was performed at 
least 30 days after the index event [48].
Multiple studies published before 2018 reported a high 
PCI procedural failure rate, even in patients with preserved 
vessel flow, reaching 30%–50% with an increased incidence 
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Figure 3. Optical coherence tomography in patient with SCAD. 49-year-old female without cardiovascular risk factors, hospitalized due to 
acute coronary syndrome without persistent ST segment elevation. Angiography depicted long smooth lumen narrowing in the mid and 
distal segment of left anterior descending (LAD) artery. Optical coherence tomography (OCT) revealed intramural hematoma propagating 
towards the distal segment of the artery (B–E). A. Healthy artery reference. SCAD type 2b has been recognized
(up to 13%) of emergency coronary artery bypass grafting 
[26, 36, 39]. For comparison, 90% of the conservatively 
managed group had an uneventful in-hospital course 
[4, 5]. However, revascularization is still required in some 
high-risk patients, and this clinical presentation is not a very 
rare phenomenon. It was observed in 7.6% of patients in 
a recently presented large Canadian SCAD population [1]. 
Major PCI indications included ongoing ischemia, high-risk 
anatomy, i.e., proximal segment dissection of large epicar-
dial arteries, and hemodynamic/cardiac rhythm instability 
[4, 5, 50]. The latest studies have provided more promising 
results of PCI. An analysis of 144 United Kingdom patients 
treated percutaneously, including stenting in 72.4% of 
cases, plain old balloon angioplasty (POBA) in 21.1%, 
and wiring in 6.4%, was presented at the ESC Congress in 
2020 [51]. The rate of all complications was high (38.8%). 
Still, the rate of significant complications, defined as flow 
reduction in proximal/middle segment, stent extension 
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into the left main artery, or iatrogenic dissection requir-
ing PCI or coronary artery bypass grafting, was only 9%, 
including predominantly (77%) iatrogenic dissection. SCAD 
lesion length was associated with the presence of compli-
cations. Also, Lobo et al. [52] showed a 91% success rate 
of PCI in a relatively small group of 33 patients presented 
with STEMI. Those with revascularization were high-risk 
patients, more likely having shock, left main as a culprit 
lesion, proximal dissection, and initial flow grade 0 to 1.
If PCI is required, special attention should be paid to 
catheter maneuvers to minimize the risk of iatrogenic dis-
section and ensure guidewire passage into the true lumen. 
The risk of false lumen propagation during stent deploy-
ment or side branch occlusion by hematoma propagation 
also needs to be considered. Therefore, the primary goal of 
revascularization should be the restoration of TIMI 3 flow 
with the least aggressive techniques possible, including 
POBA, selection of either a long stent to prevent hematoma 
propagation or focal intervention with short stent just to 
seal the entry ‘tear’ of the dissection [25, 39, 48]. The use 
of bioresorbable vascular scaffolds has been considered in 
relatively young patients and with a non-atherosclerotic, 
potentially healable, underlying condition [53]. A mul-
ticenter prospective study, including 15 high-risk SCAD 
patients who received 34 bioresorbable vascular scaffolds, 
showed very satisfactory late angiographic outcomes, with 
no significant restenosis and an excellent minimal luminal 
area and optimal coronary wall healing, as assessed after 
2 years by CCTA [54]. Case reports have also described the 
use of cutting balloons to fenestrate the intimal-medial 
membrane and depressurize the false lumen and drain 
intramural hematoma [55]. 
In patients with cardiogenic shock, without improve-
ment after PCI, or with complicated PCI, mechanical cir-
culatory support devices like intra-aortic balloon pump, 
left ventricular assist device, or extracorporeal membrane 
oxygenation may be considered as a bridge to surgical revas-
cularization or, if required, to heart transplantation [56–58].
Coronary artery bypass grafting may be considered in 
patients with left-main dissection or multivessel proximal 
SCAD when PCI is deemed to have a very high risk (due to 
high-risk anatomy) or in the case of PCI failure as a bailout 
strategy [4, 5]. Acute management of SCAD is summarized 
in Figure 4. 
Management of angiographically suspected
SCAD






Extremaly high risk anatomy
Symptoms deterioration 
with new ECG changes 
or troponin rise or hemodynamic/electric 
instability, resistant to pharmacotherapy
Clinically stable
Intracoronary imaging
in type 3 and equivocal type 2 cases
Discharge
— Active/ongoing ischemia 
— Hemodynamic/electric instability




Figure 4. Acute management of spontaneous coronary artery dissection
Abbreviations: prox, proximal; pts, patients
936
K A R D I O L O G I A  P O L S K A ,  2 0 2 1 ;  7 9  ( 7 – 8 )
w w w . j o u r n a l s . v i a m e d i c a . p l / k a r d i o l o g i a _ p o l s k a
POST-SCAD MANAGEMENT
Prognosis and post-SCAD chest pain management
The prognosis of the majority of SCAD patients is good. 
In-hospital mortality differs between patients treated inva-
sively (with worse initial presentation) and those managed 
conservatively. The in-hospital mortality of revascularized 
patients ranged from 0 to 3.5% [26, 36, 39]. For compari-
son, in a Canadian registry, including 750 patients (86.4% 
treated conservatively), in-hospital mortality was 0.1% 
(1 patient) and mortality between discharge and 30th 
day was 0% [1]. However, it should be noted that 15 of 
648 patients (2.3%) initially treated conservatively required 
revascularization during the same hospitalization. Hence, 
longer hospitalization should be considered in conserva-
tively managed patients. 
Long-term mortality after SCAD ranges from 1.2 to 
3.1% during the median follow-up period between 22 and 
37 months [14, 25, 36, 39]. In a recent study, 3-year survival 
after SCAD-related STEMI was 98% as compared to 84% 
after atheromatic STEMI [52].
Another analysis of 158 SCAD-survivors showed that 
the majority of patients have no or small infarctions and 
preserved ejection fraction as assessed in cardiac magnetic 
resonance imaging. Patients presenting with STEMI, TIMI 
0/1 flow, or multivessel SCAD, and those with connective 
tissue disorders were more likely to have larger infarcts [59]. 
Similar data regarding the infarct size have been reported 
from echocardiographic follow-up of 227 SCAD patients 
from the Canadian registry [60].
Considering the high percentage of spontaneous heal-
ing of conservatively treated SCADs and the potential risk 
for iatrogenic dissection, we do not recommend routine 
follow-up with coronary angiography in asymptomatic 
patients [48]. SCAD survivors frequently report chest pain, 
often for several months after discharge [61, 62]. Most 
chest pains are nonischemic, so for symptomatic patients 
after proximal or middle segment dissection, when ACS 
is excluded, CCTA is a reasonable diagnostic modality for 
vessel healing assessment (Figure 5A) or exclusion of in-
stent restenosis (Figure 5B) [63, 64]. In the case of distal 
segments or small vessel dissections, CCTA may be an 
Figure 5. A. SCAD healing assessment using coronary computed tomography angiography: invasive coronary angiography with long type 2a 
SCAD in LAD (left), vessel healing confirmed in control CCTA (right); B. CCTA for in-stent restenosis exclusion. From left to right: initial angiography 
with left main SCAD; final angiography after stenting; CCTA during follow-up confirming favorable late result of PCI and no in-stent restenosis 
Abbreviations: CCTA, computed tomography coronary angiography; LAD, left anterior descending; PCI, percutaneous coronary interventions; 
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inadequate imaging method. In such cases, a functional 
test for ischemia may be considered. If abnormal, coronary 
angiography should then be considered.
Recurrence of SCAD
Recurrent SCAD is defined as the presence of new spon-
taneous dissection located either in another coronary 
segment or occurring more than 30 days after the initial 
episode. Recurrent SCAD reportedly occurs predominantly 
in a previously unaffected arterial segment [49]. 
The incidence of SCAD recurrence ranges from 10 to 
22%, with the mean time of observation between 20 and 
56 months [14, 25, 36, 40, 49]. Analysis for potential pre-
dictors of recurrence is limited by the small numbers of 
patients with a second SCAD. One analysis of 216 SCAD 
survivors revealed that coronary tortuosity was statisti-
cally borderline associated with re-SCAD [65]. In another 
observational study, hypertension and β-blocker use were 
associated with increased and decreased risk of another 
SCAD, respectively [25]. As this study did not provide many 
details about the rate of blood pressure control or the type 
of drugs used, the results are hypothesis-generating rather 
than a guide to treatment and require confirmation in other 
observational studies and ultimately in a randomized trial 
[66] A further report of Clare et al., including 208 patients, 
found higher recurrence risk in patients with fibromuscular 
dysplasia and patients with a history of migraine headaches 
[2]. Statin or antiplatelet therapies were not associated with 
the increased risk. The results of recent studies on SCAD 
recurrence are summarized in Table 2. 
Medical therapy
There are no available clinical trials assessing the efficacy 
of pharmacotherapy in SCAD survivors. Optimal medical 
treatment remains undetermined. However, as hyperten-
sion is one of the predictors of recurrent SCAD, optimal 
anti-hypertensive therapy is recommended, favoring 
β-blocker as a first-choice drug where tolerated. Following 
SCAD, an assessment of left ventricular systolic function 
with echocardiography or cardiac magnetic resonance 
imaging is mandatory to guide medical therapy and to 
evaluate potential indications for device implantation.
In patients with heart failure, guideline-based pharma-
cotherapy is recommended [67]. The benefit from statin 
use is unknown, so we do not recommend a statin in 
conservatively treated patients unless they have diabetes 
mellitus or other conditions requiring primary prevention. 
In patients after stenting or with vein grafts, statins may be 
considered asthey can delay neo-atherosclerosis formation, 
at least theoretically. 
The recommended length of dual antiplatelet therapy 
(DAPT) in patients treated with stents is the same as after 
atherosclerotic ACS [68, 69]. In patients treated conserva-
tively, the benefit from the use of DAPT remains unproven. 
A pragmatic approach may be to use DAPT for at least 
3 months in asymptomatic patients. If the vessel healing 
was confirmed on CCTA or angiography (if made for clinical 
reasons), DAPT could be stopped earlier. Clinical trials are 
needed to evaluate the balance between potential benefit 
or harm from long-term therapy with aspirin in conserva-
tively treated patients with SCAD. 
Screening for fibromuscular dysplasia (FMD) and 
extracoronary vascular abnormalities (EVA)
Fibromuscular dysplasia is an idiopathic, non-atheroscle-
rotic, and non-inflammatory disease of medium-sized 
arteries characterized by abnormal cellular proliferation 
and distorted vessel wall architecture. It may affect all 
vascular beds, with renal and extracranial (carotid or 
vertebral) arteries most commonly affected and uncom-
mon multivessel involvement (Figure 6) [70]. The typical 
morphological presentation includes two types of FMD: 
focal, which may occur in any part of the artery, and multi-
focal- with alternating areas of stenosis and dilation (called 
a ‘string of beads’), which usually appears in middle and 
distal segments of the artery (Figure 6) [70]. 
The coexistence of SCAD and FMD was first reported 
in 2005 [71]. The prevalence of FMD in SCAD survivors 
reported in several studies ranged from 10% to 86%, 
depending on the percentage of patients undergoing full 
screening [5]. Systematic evaluation substantially increases 
the sensitivity in FMD detection. In the largest cohort of 
the Canadian registry, 411 of 750 included patients were 
systematically evaluated, and FMD was found in 56.7% 
Table 2. Prevalence and predictors of SCAD recurrence
Author 
(year of publication)
Patients with recurrent 
SCAD/all patients
Recurrence rate, % Follow-up, months Predictors of SCAD recurrence
Eleid (2014) 40/246 16.2 20.5 Tortuosity ↑
Nakashima (2016) 14/63 22.2a 34 NA
Saw (2017) 34/327 10.4 37 Hypertension ↑
β-blockers use ↓
Kok (2018) 88/585 15 31 NAb
Claire (2019) 22/208 10.6 56.4 Migraine ↑
Fibromuscular dysplasia ↑
aHalf of patients experienced recurrence of SCAD within 30 days after index event.
bRecurrent chest pain within first 30 day after SCAD was more frequently reported in patients with migraine, however migraine was not related to 5-year SCAD recurrence
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of  them [1]. The  prevalence of renal, cerebrovascular, 
and iliac/femoral FMD was 27.7%, 29.5%, and 21.0%, re-
spectively. In a Mayo Clinic cohort, 335 of 585 included 
patients were screened and the frequency of FMD lesions 
was 58% [72]. Carotid/cerebral FMD was detected in 28%, 
body FMD in 52% of cases. FMD may also be more frequent 
in SCAD patients with a higher coronary tortuosity score 
[65]. In the ARCADIA-POL study, including 232 patients 
with FMD, systematic evaluation including “head-to-pelvis” 
computed tomography angiography resulted in detection 
of new FMD lesions in 34.1% of patients and previously 
undiagnosed vascular complications in 25% of subjects 
[73]. These findings require confirmation in SCAD-cohort 
observational studies. 
The other EVAs found in patients with SCAD are aneu-
rysms, dissections, and tortuosity, suggesting that SCAD 
may be the initial presentation of underlying arteriopathy 
(Figure 6) [4, 5]. In the abovementioned Mayo Clinic, cohort 
EVAs were detected in 23% of patients [72]. The preva-
lence of cerebral aneurysms reported in multiple studies 
ranged from 7.1% to 22.5% [1, 8, 72, 74]. This finding may 
be clinically important as some aneurysms may require 
intervention or systematic follow-up depending on their 
size or morphology [75]. 
Therefore, the group of experts from ACVI recom-
mends whole-body computed tomography or magnetic 
resonance angiography screening (from head to pelvis) 
for fibromuscular dysplasia and EVA presence in all SCAD 
survivors. 
Cardiac rehabilitation, psychotherapy
In general, there is no contraindication to usual physical 
activity in patients after SCAD to avoid weight gain or 
deconditioning. However, patients should be advised to 
avoid prolonged high-intensity activities, highly com-
petitive or contact sports, and activities performed to 
exhaustion (racing, boot camp) [6]. Exercise training should 
be low resistance with high repetitions to avoid strain or 
Valsalva maneuver. Cardiac rehabilitation is recommended 
in all patients as it is safe and psychologically beneficial. It 
reduces symptoms of chest pain, depression, and stress [61, 
76]. SCAD survivors are at the risk of posttraumatic stress 
disorder, depression, and anxiety, which are associated 
with lower quality of life [77, 78]. Given the prevalence and 
potential impact, screening and treatment for psychologi-
cal distress are advised. Behavioral interventions targeted 
toward resilience training may be beneficial.
Genetics
 Only a few reports of familial SCAD suggest it is not inher-
ited disease in most cases [79, 80]. Rare causal pathogenic 
genetic variants occur in a minority of SCAD patients, most-
ly associated with known concomitant connective tissue 
diseases, like Ehlers-Danlos, Marfan, Loeys-Diez syndrome, 
or polycystic kidney disease [5]. 
Recently, the first common genetic variant for SCAD has 
been identified. In the largest study conducted, including 
1055 SCAD patients and 7190 case controls, the authors 
found an association between rs9349379 genotype of 
A B C
D E F
Figure 6. Extracoronary vascular abnormalities and comorbidities in patients with SCAD. A. Renal focal FMD. B. Renal multifocal FMD.  
C. Carotid FMD. D. Renal artery aneurysm. E. Carotid artery aneurysm. F. Tortuosity od carotid arteries
Abbreviations: FMD, fibromuscular dysplasia; SCAD, spontaneous coronary artery dissection
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PHACTR1/EDN1 (phosphatase and actin regulator 1) gene 
on chromosome 6q24 and the incidence of SCAD [81]. 
Rs9349379-A allele was related to the increased risk of SCAD. 
This genotype was also associated with other vascular dis-
eases, including FMD, coronary artery disease, migraine, and 
cervicocerebral artery dissection in previous reports [82–85]. 
In another report, evaluating 667 women with SCAD 
and 1477 female controls, the authors from Mayo Clinic 
identified 5 risk loci associated with SCAD, including previ-
ously described locus (1q21.3; 6p24.1; 12q13.3; 15q21.1 and 
21q22.11). The alternative alleles of 3 of them have also 
been reported to be linked with atherosclerotic coronary 
artery disease. It suggests an opposite susceptibility to 
coronary atherosclerosis vs dissection [86]. 
These findings were confirmed in another trial evalu-
ating 270 SCAD cases and 5263 controls. The authors also 
identified the rs12740679 allele at chromosome 1q21.2, 
implicating the extracellular matrix protein-encoding 
gene ADAMTSL4, to be significantly associated with 
SCAD. Moreover, the previously reported chromosome 
6p24.1 PTACTR1 locus (rs9349379) and the 12q13 LRP1 lo-
cus (rs11172113) were also associated with the risk of SCAD 
in the meta-analysis of the genome-wide SCAD discovery 
and replication results. Interestingly, all three loci have been 
described in association with migraine headaches. The au-
thors developed and tested a genetic risk score and demon-
strated not only the association with SCAD occurrence 
but also opposing risks of atherosclerotic vs SCAD-related 
myocardial infarction [87].
In a very recent British genome sequencing study in-
cluding 476 SCAD survivors and 13722 controls, pathogenic 
or likely rare pathogenic variants were detected in 3.5% 
of SCAD cases in 7 genes (PKD1, COL3A1, SMAD3, TGFB2, 
LOX, MYLK, and YY1AP1, with the highest association of 
the PKD1 gene with SCAD [88]. The results strengthen the 
overlap between SCAD and renal and connective tissue 
disorders. More studies are needed to confirm this finding.
So, at present, the group of experts does not recom-
mend routine genetic screening. It can be considered in 
individuals with suspicion of connective tissue disease, 
extensive arteriopathies, or a strong family history of 
arteriopathies. 
Pregnancy after SCAD and contraception
The risk of SCAD recurrence during pregnancy following 
a prior SCAD is poorly understood. Recently, the results of 
636 women, including 23 patients who became pregnant 
(32 pregnancies) after SCAD, were published [89]. In the 
overall cohort, recurrent SCAD occurred in 122 patients. The 
study did not find evidence for an increased risk of SCAD 
recurrence in patients who became pregnant after SCAD 
when compared with women who did not experience 
pregnancy after an episode of SCAD. However, the results 
are limited by the small total number of women with preg-
nancy after SCAD, so should be interpreted with caution. 
So any decision on planning pregnancy should be carefully 
discussed with the pregnancy heart team, taking into ac-
count many aspects like left ventricular ejection fraction, 
maternal age, risk of recurrence, comorbidities, and tera-
togenic medications. In general, planned pregnancy is not 
contraindicated, but this decision should be individualized. 
Unplanned pregnancy should be avoided, and effective 
secure contraception is therefore important. Non-hormonal 
contraception is recommended  such as non-hormonal 
intrauterine device or surgical sterilization of the patient 
or  partner may also be a reasonable option. If hormonal 
contraception is required, despite the lack of studies 
in SCAD patients, highly effective progesterone-based 
approaches are preferable, including the long-acting sub-
dermal levonorgestrel implant or levonorgestrel-releasing 
intrauterine device [90]. 
PREGNANCY-ASSOCIATED SCAD (P-SCAD)
The incidence of P-SCAD, assessed in a population-based 
cohort study including 4.3 million pregnancies, was 
1.81 per 100  000 [91]. The following overlapping mech-
anisms associated with pregnancy were hypothesized to 
have an etiological role in P-SCAD [92]: (1) increased cardiac 
output with secondary increased arterial shear stress; (2) 
excess progesterone leading to the loss of normal corruga-
tion of elastic fibers, a decrease in acid mucopolysaccharide 
ground substance and weakening the tunica media; (3) 
excess estrogen facilitating matrix metalloproteinases 
release leading to cystic medial necrosis and lack of vasa 
vasorum structural support; (4) impaired collagen synthesis 
in the peripartum period.
P-SCAD is a common cause of ACS during pregnancy 
and the postpartum period, reaching up to 10% of all such 
ACS events [93, 94]. Chronic hypertension, lipid profile 
abnormalities, chronic depression, and history of migraine 
were associated with an increased risk for P-SCAD in one 
study [91].
P-SCAD patients are usually characterized by a more 
severe clinical course, including a higher risk of cardiac 
arrest, ventricular arrhythmia, and cardiogenic shock. This 
results from increased left mainstem involvement and 
multivessel dissection [23, 92, 95]. Multivessel involve-
ment supports the hypothesis of generalized arterial wall 
changes under hormonal changes during pregnancy. 
STEMI ACS is diagnosed using ECG in approximately 60% 
of P-SCAD patients. The long-term prognosis after P-SCAD 
may worsen as the left ventricle ejection fraction is lower 
than in patients with SCAD not related to pregnancy; they 
also require implantable cardiac devices more frequently 
[23]. On the other hand, the risk of SCAD recurrence is 
comparable to other SCAD patients [23]. 
FILLING THE GAPS  
AND GLIMPSE INTO THE FUTURE
We presented recommendations on the diagnosis and 
management of spontaneous coronary artery dissection. 
Many questions, like the underlying pathophysiology, the 
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Table 3. Summary of recommendations in SCAD management
DIAGNOSIS
SCAD should always be considered in the differential diagnosis of ACS 
presentations, particularly in the low-risk population of young and middle
-aged women
Invasive coronary angiography remains the gold standard for the diagno-
sis of SCAD but should be performed with caution due to the increased 
risk for iatrogenic dissection
CCTA made in triple “rule-out” protocol may be false negative in SCAD pa-
tients. In case of confirmed myocardial necrosis in young or middle-aged 
women presenting with ACS, coronary angiography should be considered 
despite negative CCTA result
Intravascular imaging (preferentially OCT) is recommended in 2 primary 
clinical scenarios: ambiguous angiographic lesions, mainly type 3 as this 
is indistinguishable from atherosclerotic lesion, and in selected patients 
with type 2, especially when the clinical profile is not indicative for high 
atherothrombotic risk 
TREATMENT
Conservative management should be a default strategy for low-risk pa-
tients with NSTEMI, maintained coronary flow and more distal dissection 
since spontaneous healing of the vessel wall is observed in the majority of 
patients and coronary revascularization is associated with an increased risk 
of complications
Coronary revascularization, preferentially PCI, is recommended in high-risk 
clinical and angiographic scenarios, including ongoing ischemia related 
to large vessel dissection, proximal dissection, hemodynamic or electrical 
instability
Coronary artery bypass grafting is recommended in patients with left-ma-
in dissection or multivessel proximal SCAD when PCI is considered to have 
a very high risk or in case of PCI failure as a bailout strategy
POST-SCAD MANAGEMENT
Optimal blood pressure control in hypertensive patients is recommended 
for secondary prevention of SCAD recurrence, with β-blocker preference as 
a first-choice drug, if not contraindicated
An assessment of left ventricular systolic is mandatory to guide medical 
therapy and to assess potential indications for device implantation. Guide-
lines-guided heart failure pharmacotherapy is recommended, if present 
after SCAD occurrence
The recommended length of dual antiplatelet therapy (DAPT) in patients 
treated with stents is the same as after atherosclerotic ACS. In patients 
treated conservatively, we advise using DAPT for at least 3 months in 
asymptomatic patients
For symptomatic patients after proximal or middle segment dissection, 
when ACS is excluded, CCTA is a reasonable modality for vessel healing 
assessment or in-stent restenosis exclusion. In the case of distal segments 
or small vessel dissections, CCTA may be an inadequate imaging method, 
and functional tests detecting ischemia are recommended. If they are 
abnormal, coronary angiography should be considered if revascularization 
is feasible and may be beneficial
Screening for fibromuscular dysplasia and the presence of extracoronary 
vascular abnormalities using “head-to-pelvis” CCTA arterial imaging is 
recommended
Usual physical activity is not contraindicated. Prolonged high-intensity 
activities, highly competitive or contact sports and activities performed to 
exhaustion should be avoided. Screening and treatment for psychological 
distress are strongly advised
The decision on planning pregnancy should be carefully individualized 
and discussed with the pregnancy heart team. Non-hormonal contracep-
tion is recommended for avoiding unplanned pregnancy — surgical steri-
lization may be a reasonable option. If hormonal contraception is required, 
highly effective mono-hormonal contraception should be used, including 
the long-acting subdermal levonorgestrel implant or levonorgestrel-rele-
asing intrauterine device 
Routine genetic screening is not recommended. It can be considered in in-
dividuals with suspicion of connective tissue disease, aneurysm presence, 
or a family history of arteriopathies 
Abbreviations: ACS, acute coronary syndrome; CCTA, computed tomography coro-
nary angiography; NSTEMI, non-ST segment elevation myocardial infarction; OCT, 
optical coherence tomography; PCI, percutaneous coronary interventions; SCAD, 
spontaneous coronary artery dissection
role of female sex hormones in the pathogenesis, the role 
and optimal duration of antiplatelet therapy, the identi-
fication of recurrence risk factors, the use of β-blockers, 
statins, or other potential secondary prevention drugs 
remain unresolved. The ESC has designed and just opened 
the European registry of SCAD survivors, including both 
prospective and retrospective subjects. Collecting data 
from >1000 patients will increase our knowledge and 
understanding of this mysterious disease. In Poland, the 
registry is coordinated by the National Institute of Cardi-
ology, Warsaw. More information is available by e-mail: 
scad@ikard.pl
All recommendations presented in this document are 
summarized in Table 3. 
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